Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. nanoparticle
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Nanoparticle Articles & Analysis: Older

94 news found

Precision Aerosol Therapy Through AI and flexiVent-Controlled Delivery

Precision Aerosol Therapy Through AI and flexiVent-Controlled Delivery

Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in ...

BySCIREQ - an emka TECHNOLOGIES Company


Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities

Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities

A wide range of lyophilized flash-release formulation types can be developed by Protheragen-ING, which include: particles, nanoparticles, films, microspheres, and fiber bundles. Moreover, Protheragen-ING’s expert team can design and develop the most appropriate lyophilized flash release formulations based on client's needs and requirements. ...

ByProtheragen-ING


CD Formulation Is A Reliable Provider of Customized Drug Conjugates Services

CD Formulation Is A Reliable Provider of Customized Drug Conjugates Services

These non-infectious protein nanoparticles facilitate efficient drug transport, unlocking new possibilities in drug delivery systems. ...

ByCD Formulation


Liposomes for Food Applications

Liposomes for Food Applications

It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research ...

ByCD Bioparticles


Immune System Tissue Microarrays for Research Usage

Immune System Tissue Microarrays for Research Usage

Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein ...

ByCD BioSciences


Biopharma PEG Expands GMP Production of Lipids and PEGs to Meet Growing Demand for Lipid Nanoparticles

Biopharma PEG Expands GMP Production of Lipids and PEGs to Meet Growing Demand for Lipid Nanoparticles

This strategic move is aimed at addressing the rising global demand for Lipid Nanoparticles (LNPs), which are vital for nucleic acid drug delivery, especially in mRNA-based therapies and vaccines. Lipid Nanoparticles have become a groundbreaking delivery mechanism within the biopharmaceutical sector. ...

ByBiopharma PEG Scientific Inc


Ace Therapeutics Unveils Next-Generation Drug Delivery Technologies for Glaucoma

Ace Therapeutics Unveils Next-Generation Drug Delivery Technologies for Glaucoma

By utilizing next-generation technologies such as nanoparticles, in-situ gel, hydrogel, and dendrimer, Ace Therapeutics' drug delivery systems can ensure the right amount of medication is administered at the right time, optimizing treatment outcomes and minimizing side effects. ...

ByAce Therapeutics


CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

About CD Bioparticles CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. ...

ByCD Bioparticles


CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays

CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays

Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein ...

ByCD BioSciences


CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery

CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery

For example, the 113-O12B-Lipid Nanoparticles Targeted to Lymph Nodes (Catalog: CDCLP24-013-L), the specific lipids synthesized, can allow specific lymph node targeting. ...

ByCD Bioparticles


CD Formulation Develops, Evaluates, and Utilizes Innovative Drug Delivery Technologies for the Pharmaceutical Industry   

CD Formulation Develops, Evaluates, and Utilizes Innovative Drug Delivery Technologies for the Pharmaceutical Industry  

Nanoformulations involve the use of nanoparticles to deliver drugs to targeted sites in the body, allowing for more precise and effective treatment,” said Marketing Chief of CD formulation. ...

ByCD Formulation


CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications

CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications

It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research ...

ByCD Bioparticles


CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

CD Bioscience has been developing imaging technologies for many years and uses high content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging and other technologies to image cellular structures, cell migration, cell proliferation, pathogen infection mechanisms and protein molecule interactions. ...

ByCD BioSciences


CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research ...

ByCD Bioparticles


Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology

Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology

The multi-target research and development partnership will focus on severe skin diseases The collaboration leverages etherna’s proprietary mRNA and lipid nanoparticle (LNP) technology with Almirall’s expertise in the dermatology space In addition to upfront and technology access payments, etherna is eligible to receive €300 million in development and ...

ByeTheRNA


The European Commission requests a second scientific opinion on Hydroxyapatite (nano) based on new evidence provided by industry

The European Commission requests a second scientific opinion on Hydroxyapatite (nano) based on new evidence provided by industry

Following a previous SCCS conclusion on the safety of Hydroxyapatite (nano) when used at concentrations up to 10 % in toothpaste, and up to 0.465 % in mouthwash regarding rod-shaped Hydroxyapatite (nano) particles (see SCCS opinion Hydroxyapatite March 2023), industry has provided new evidence on the safety of Hydroxyapatite (nano) which now has turned into a new opinion ...

ByNanotechnology Industries Association (NIA)


Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics   

Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics  

Through its expertise in various cutting-edge technologies such as microneedle and thin film technologies, transdermal patches, microencapsulation, and nanoparticle development, CD Formulation is revolutionizing the way drugs are delivered to patients, ultimately improving pharmacokinetics and pharmacodynamics. ...

ByCD Formulation


mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board

mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board

These include molecular designs, lipid biochemistry expertise, customized lipid nanoparticle formulations (cLNPs), mRNA-based T cell adjuvants, and advanced manufacturing processes, and they overcome the current challenges facing the development of mRNA therapeutics. etherna’s business model utilizes this suite of capabilities as enablers to deliver superior products for ...

ByeTheRNA


CD BioSciences Launches New 3D Tissue Imaging Services

CD BioSciences Launches New 3D Tissue Imaging Services

Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein ...

ByCD BioSciences


CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems   

CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems  

In addition to CAR-T/CAR-NK cells development, CD Formulation also provides other novel drug delivery system services, including: Microneedle Technology, Oral Thin Films Drug Delivery, Transdermal Patches Drug Delivery System, Microencapsulation Drug Delivery System, Nanoparticle Development, Microparticle Depots Design and Development, Emulsion Formulation, Coupled Targeted ...

ByCD Formulation

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT